Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon Aug 06, 2021 1:27pm
88 Views
Post# 33664004

RE:2.5 Million Shares Cancelled

RE:2.5 Million Shares Cancelled
gudisgood wrote: The buybacks continued throughout July.

Issuer Name
Knight Therapeutics Inc.
Insider Name
Knight Therapeutics Inc.
Filing Date
Aug 04, 2021
Transaction Date
Jul 30, 2021
Security Type
Common Shares
Transaction Nature
38 - Redemption, retraction, cancellation, repurchase
Ownership Type
Direct Ownership
Registered Holder
# or Value Acquired or Disposed of
-2,562,727



Your optimism is misplaced. This has all the signs of a privatization by the founder. All this does is burn shareholder money and make it cheaper for him. The business plan has been an epic fail and what worked 10 years ago is not applicable today and the market has spoken. At best we get a 10-15% premium to trading price and one of the worst performing companies in the country for 1-3-5 year periods gets taken private. 
<< Previous
Bullboard Posts
Next >>